\
&
Contact us
\
&
Contact us
Published on | 2 weeks ago
Programmes HealthThe European Partnership ERA4Health has opened its seventh Joint Transnational Call that will fund 'Multi-country Investigator Initiated Clinical Trials in Cardiovascular, Autoimmune and Metabolic diseases' (Trials4Health).
The aims of the call are:
- to support randomised interventional multi-country Investigator-Initiated Clinical Studies that are designed as pragmatic comparative-effectiveness studies and/or drug repurposing studies.
- to encourage and enable transnational collaboration between clinical/public health research teams (from hospital/ public health, healthcare settings and other healthcare organisations) that conduct multi-country IICS, either comparative-effectiveness or drug repurposing studies.
Note that clinical studies conducted for direct commercial purposes are excluded from support by the ERA4Health programme. In the case of the involvement of any private for-profit entity, it is needed that the consortia duly justify their role in the proposal and that there is no commercial purpose or benefit.
Belgium participates in the call with KCE Trials acting as Belgian funding organisation. Find out who can submit at Belgian level and the details of the additional requirements for Belgium here.
Find out more about the call and conditions to apply on the ERA4Health dedicated webpage. Deadline for pre-proposal submission is 27 January 2026. Documents required at national level and a copy of the pre-proposal must be sent by e-mail to KCE within the same deadline (trials@kce.fgov.be).
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
ChemStream is an innovative chemical R&D company, specialized in translating material problems in sustainable formulations with focus on nano-dispersions, functional coatings and inkjet inks. Within LORCENIS they will develop super absorbing polymers (SAPs) to be mixed within the concrete matrices for improving the active internal curing, self-healing and self-sealing properties of the concrete. Grindig SAPs.
ChemStream bvba and Ghent University are involved in Horizon 2020-project for developing long lasting reinforced concrete for energy infrastructures.
